CD19/CD20 Dual-CAR-T cells
HXYT-007
Phase 1 mab completed
Quick answer
CD19/CD20 Dual-CAR-T cells for B-cell Leukemia is a Phase 1 program (mab) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- B-cell Leukemia
- Phase
- Phase 1
- Modality
- mab
- Status
- completed